Pathogenesis and Treatment of Acne
A special issue of Dermato (ISSN 2673-6179).
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 9232
Special Issue Editors
Interests: cannabinoid signaling; phytocannabinoids; mitochondrial biology; acne; (patho)biology of hair follicles; inflammatory skin diseases
Interests: acne; sebocytes; lipids, isotretinoin; skin inflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Acne is one of the most common skin diseases. Although it is not a directly life-threatening condition, it can severely impair the quality of life of patients, leading to psycho-emotional distress characterized by, e.g., anxiety, depression, or suicidal ideation.
Importantly, although our knowledge on the pathogenesis of the disease has expanded substantially in recent years, no new chemical entities (i.e., not combinations or derivatives of previously introduced drugs) have been approved by the FDA in the last two decades for the treatment of acne. Thus, considering the potentially severe side effect profile of the top anti-acne agents (e.g., isotretinoin), there is an unmet demand from the medical community, pharmaceutical industry, and society to find new, efficient, yet safe solutions to treat acne.
To respond to this challenge, this Special Issue calls for original research, reviews, case studies, and perspectives that may expand the current knowledge on the pathogenesis of acne and thereby have the potential to lead to the development of innovative, new approaches in the treatment of the disease.
Dr. Attila Oláh
Dr. Dániel Törőcsik
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Dermato is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Acne
- C. acnes
- Comedogenesis
- Inflammation
- Immune cells
- Microbiota–host communication
- Sebaceous gland
- Seborrhea
- Lipids
- Signaling
- Therapeutic target
- Scarring
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
